Factor X Activation via Anion Exchange Resin Autoactivation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for activating Factor X (FX) require the use of exogenous agents, which may introduce contaminants and complicate the process.

Innovation Solution

FX is activated through association with a chromatography resin, specifically an anion exchange resin, in a controlled environment with varying conditions such as conductivity, pH, and temperature, without the addition of external agents.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If exogenous agents are used to activate FX, then activation efficiency is improved, but product purity is worsened due to contaminant introduction

Engineering Contradiction:
Improveactivation efficiencyVSAvoidproduct purity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent enables FX to activate itself through autoactivation when bound to the chromatography resin, eliminating the need for exogenous proteases. This self-service mechanism resolves the contradiction by achieving activation without introducing external agents that would contaminate the product, thus maintaining both activation efficiency and product purity

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The chromatography resin serves as an intermediary that facilitates FX activation. By binding FX to the resin, the system creates a controlled environment where autoactivation occurs without requiring external proteases. The resin mediates the activation process while being easily removable, thus preserving product purity while enabling efficient activation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Speed

If exogenous proteases are used for FX activation, then activation speed is improved, but process complexity is worsened

Engineering Contradiction:
Improveactivation speedVSAvoidprocess complexity
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The method eliminates the need for external protease addition by enabling FX autoactivation upon resin binding. This self-service approach simplifies the process by removing multiple steps (protease addition, incubation, protease removal) while maintaining activation speed through the resin-facilitated autoactivation mechanism

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent combines the purification and activation steps into a single integrated process. By performing both FX purification and activation during the chromatography resin binding process, the method reduces overall process complexity while maintaining both purification quality and activation efficiency

Inventive Principle:
Principle #5Merging (Combining)

3Manufacturing precision

If FX is activated without exogenous agents, then product purity is improved, but activation reliability is worsened

Engineering Contradiction:
Improveproduct purityVSAvoidactivation reliability
Core Design Contradiction:
Manufacturing precisionVSReliability

Solution Approach 1:

The chromatography resin acts as a reliable intermediary that ensures consistent FX activation. By providing a controlled binding environment with specific resin types (anion exchange, cation exchange, or affinity resins), the system achieves reliable autoactivation without exogenous agents, resolving the contradiction between purity and reliability

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The method optimizes activation reliability by controlling key parameters including pH (6-9), temperature (4-37°C), and resin binding conditions. These parameter optimizations ensure that FX reliably activates through autoactivation when bound to the resin, maintaining both product purity and activation reliability

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively activates FX to its active form (FXa) without external agents, providing a cleaner and more controlled activation process, as demonstrated by successful activation and purification results.

Implementation Method 1

FX is activated through associating the FX with a chromatography resin, specifically an anion exchange resin

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Data Source

PatentEP3180355B1Factor x activation
Publication Date: 2019.07.31 BAXALTA INC
  • EP3180355B1 patent drawingFigure 1

AI summary

Methods and systems for activating Factor X are disclosed